Sep 28 Sep 28 Jeffrey Conn, founding director of Warren Center for Neuroscience Drug Discovery, named 2021 fellow of American Society for Pharmacology and Experimental Therapeutics Guest User
Apr 13 Apr 13 Vanderbilt-developed obesity treatments will be advanced through collaboration with Soleno Therapeutics Guest User
Feb 25 Feb 25 Soleno Therapeutics announces Collaboration with Vanderbilt University to Discover and Develop Next Generation K (ATP) Channel Activators for the Treatment of Rare Diseases. Guest User